Epidemiological aspects of the incidence of thyroid cancer in the Russian Federation

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The results of an analysis of the incidence of thyroid cancer (thyroid cancer) in the Russian Federation (2008−2018) are presented. With increasing age, the incidence of thyroid cancer increases. Dominated by people aged 55 years and above (52.9%). Over the 10-year period (2008−2018), the increase in the “rough” indicator of the incidence of thyroid cancer was 49.03%, the standardized − 43.5%. The prevalence of thyroid cancer among the population of the Russian Federation in 2018 amounted to 114.1 per 100,000 population, which is 52.5% higher than in 2008 (74.8). This is due to several reasons: the demographic aging of the population, an increase in the incidence rate, and an improvement in the detection of the disease among the population (from 17.4% in 2008 to 34.3% in 2018). There was an increase in the share of thyroid cancer patients registered in oncological institutions of the Russian Federation for 5 years or more from the moment of diagnosis (from 61.6% to 68.8%, respectively), and the index of accumulation of patients with thyroid cancer (from 12.4 to 13.9 respectively). In the cohort of thyroid cancer patients, identified actively, the proportion of patients with a tumor process of stage I−II was 77.7%, and with a running tumor process (stage III−IV) — 21%. There is a differentiation of the territories of the Russian Federation both in terms of early detection and morphological verification of thyroid cancer, and the volume of radical treatment and the use of various methods for its implementation.

Full Text

Restricted Access

About the authors

Marina A. Shurgaya

Russian Medical Academy of Continuous Professional Education (FSBEI FPE RMACPE)

Author for correspondence.
Email: daremar@mail.ru
ORCID iD: 0000-0003-3856-893X

MD, PhD

Russian Federation, 2/1 Barrikadnaya St., 123995 Moscow

Gagic E. Pogosyan

E.O. Mukhina City Clinical Hospital of the Moscow City Healthcare Department

Email: offi.gp@gmail.com
ORCID iD: 0000-0002-4437-320X

MD, PhD

Russian Federation, Moscow

Sergey N. Puzin

Federal Scientific Clinical Center for Resuscitation and Rehabilitation (FNKC RR); Sechenov First Moscow State Medical University (Sechenov University)

Email: s.puzin2012@yandex.ru
ORCID iD: 0000-0003-1030-8319

MD, PhD, Professor, Academician of the Russian Academy of Sciences

Russian Federation, Moscow; Moscow

Evgeniy E. Achkasov

Russian Medical Academy of Continuous Professional Education (FSBEI FPE RMACPE)

Email: 2215.g23@rambler.ru

MD, PhD, Professor

Russian Federation, Moscow

Servir S. Memetov

Rostov State Medical University (FSBEI HE RostSMU)

Email: memetov.57@mail.ru
ORCID iD: 0000-0002-6804-0717

MD, PhD, Professor

Russian Federation, Rostov-on-Don

References

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Prevalence of thyroid cancer among the population of the Russian Federation (2008−2018, per 100,000 adult population)

Download (137KB)
3. Fig. 2. Distribution of newly diagnosed cases of thyroid cancer in the territories of the Russian Federation by the prevalence of the tumor process (2018,%)

Download (253KB)

Copyright (c) 2020 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86505 от 11.12.2023 г
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80654 от 15.03.2021 г
.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies